Evaluation of CD4 Count in HIV Infected Pregnant Women at Kibagabaga Level Two Teaching Hospital
Abstract
CD4 count measures the degree of immunosuppression in HIV-positive patients and is used to monitor HIV infection progression in human body. HIV is a virus that attacks the body’s immune system and if not treated, can lead to AIDS The rate of CD4 cells destruction is directly proportional to progressive replication of HIV. Pregnant women infected with HIV have high risk of mother to child transmission of HIV infection and are prone to excessive immunosuppression and increased viral load if their CD4 cell count is not properly maintained. Pregnancy may influence CD4 cells count reduction or don’t, that’s why this study focused on evaluation of CD4 count in HIV infected pregnant women. The objectives of this study were to determine the association between pregnancy trimesters and CD4 count among HIV infected pregnant women at KDH. The study was a cross sectional study which included 46 patients who visited kibagabaga level two teaching hospital in 5 months. Data were obtained by collecting venous blood of patients, testing their CD4 count and use of a questionnaire to evaluate the risk factors associated with changes in CD4 count. Data collected were analysed using statistical package for social sciences (SPSS) software version 22.0 and Microsoft word, the presentation of results was done using tables. Variables with p-value less than or equal to 0.05 were considered statistically significant. The study showed that there is an association between pregnancy trimesters and CD4 count among HIV infected pregnant women where 21(45.6%) women were in third trimester and had the highest CD4 count compared to women in the 2nd trimester 14(30.4%) followed by women in 1st trimester 11(24%) with p-value of 0.04 which is statistically significant. In evaluated CD4 count changes, associated risk factors were, antiretroviral treatment intake, diet intake, education level, pregnancy trimester, and closely spaced pregnancies. Which were found to have p-values 0.00, 0.00, 0.04, 0.04 and 0.01 that were statistically significant respectively.
Keywords: HIV, CD4 Count, Pregnant women
Keywords:
HIV, CD4 Count, Pregnant women, HIV, CD4 Count, Pregnant womenDOI
https://doi.org/10.22270/jddt.v14i5.6513References
Ceccarelli, G., Giovanetti, M., Sagnelli, C., Ciccozzi, A., d'Ettorre, G., Angeletti, S., & Ciccozzi, M. Human Immunodeficiency Virus Type 2: The Neglected Threat. Pathogens, 2021; 10(11), 1377. https://doi.org/10.3390/pathogens10111377 PMid:34832533 PMCid:PMC8621479
Gondivkar, S., Sarode, S. C., Gadbail, A. R., Yuwanati, M., Sarode, G. S., Gondivkar, R. S., & Awan, K. H. Oro-facial opportunistic infections and related pathologies in HIV patients: A comprehensive review. Disease-a-Month, 2021; 101170. https://doi.org/10.1016/j.disamonth.2021.101170 PMid:33618831
World Health Organization. Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV: interim guidelines: supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection (No. WHO/CDS/HIV/18.51). World Health Organization. 2018
Scorza, P., Merz, E. C., Spann, M., Steinberg, E., Feng, T., Lee, S., ... & Monk, C. Pregnancy-specific stress and sensitive caregiving during the transition to motherhood in adolescents. BMC Pregnancy and Childbirth, 2021 ;21(1), 1-8. https://doi.org/10.1186/s12884-021-03903-5 PMid:34187393 PMCid:PMC8243904
World Health Organization. Consolidated guideline on sexual and reproductive health and rights of women living with HIV. World Health Organization. 2017
Slavin, H. Improving health and social well-being. Higher Education and International Capacity Building: Twenty-Five Years of Higher Education Links, 2009 ;79-94.
Mikyas, Y., Aziz, N., Harawa, N., Gorre, M., Neagos, N., Nogueira, M., ... & Plaeger, S. Immunologic activation during pregnancy: serial measurement of lymphocyte phenotype and serum activation molecules in HIV-infected and uninfected women. Journal of Reproductive Immunology, 1997 ;33(2), 157-170. https://doi.org/10.1016/S0165-0378(97)00018-1 PMid:9234214
Ahdieh, L. Pregnancy and infection with human immunodeficiency virus. Clinical Obstetrics and Gynecology, 2001; 44(2), 154-166. https://doi.org/10.1097/00003081-200106000-00006 PMid:11344985
Ekouevi, D. K., Inwoley, A., Tonwe-Gold, B., Danel, C., Becquet, R., Viho, I., ... & Leroy, V. Variation of CD4 count and percentage during pregnancy and after delivery: implications for HAART initiation in resource-limited settings. AIDS research and human retroviruses, 2007 ;23(12), 1469-1474. https://doi.org/10.1089/aid.2007.0059 PMid:18160003
Hel Z, McGhee JR, Mestecky J. HIV infection: first battle decides the war. Trends Immunol. 2006;27(6):274-281. https://doi.org/10.1016/j.it.2006.04.007 PMid:16679064
Zuckerman AJ, Banatvala JE, Griffiths P, Schoub B, Mortimer P, editors. Principles and Practice of Clinical Virology. 6th ed. Hoboken, NJ: John Wiley and Sons Ltd; 2009. https://doi.org/10.1002/9780470741405
Brettle, R. P., Raab, G. M., Ross, A., Fielding, K. L., Gore, S. M., & Bird, A. G. HIV infection in women: immunological markers and the influence of pregnancy. AIDS (London, England), 1995; 9(10), 1177-1184. https://doi.org/10.1097/00002030-199510000-00010 PMid:8519455
BRANCH, D. W. Physiologic adaptations of pregnancy. American Journal of Reproductive Immunology, 1992 ;28(3‐4), 120-122. https://doi.org/10.1111/j.1600-0897.1992.tb00771.x PMid:1285859
Lindgren, S., Martin, C., Anzén, B., Strand, H., Bredberg-Rådén, U., & Ehrnst, A. Pattern of HIV viraemia and CD4 levels in relation to pregnancy in HIV-1 infected women. Scandinavian journal of infectious diseases, 1996; 28(5), 425-433. https://doi.org/10.3109/00365549609037933 PMid:8953667
Wang, B., Losina, E., Stark, R., Munro, A., Walensky, R. P., Wilke, M., ... & Wood, R. Loss to follow-up in a community clinic in South Africa-roles of gender, pregnancy and CD4 count. South African Medical Journal, 2011 ;101(4), 253-257. https://doi.org/10.7196/SAMJ.4078 PMid:21786730 PMCid:PMC3834586
Akinbami, A. A., Gbadegesin, A., Ajibola, S. O., Uche, E. I., Dosunmu, A. O., Adediran, A., & Sobande, A. Factors influencing CD4 cell count in HIV-positive pregnant women in a secondary health center in Lagos, Nigeria. Hiv/aids (Auckland, NZ), 2015; 7, 115. https://doi.org/10.2147/HIV.S80137 PMid:25914558 PMCid:PMC4401335
Mostad, S. B., Overbaugh, J., DeVange, D. M., Welch, M. J., Chohan, B., Mandaliya, K., ... & Kreiss, J. K. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. The Lancet, 1997;350(9082), 922-927. https://doi.org/10.1016/S0140-6736(97)04240-2 PMid:9314871
Published
Abstract Display: 224 
PDF Downloads: 246 PDF Downloads: 23 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.